Sit Investment Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Sit Investment Associates’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-392,500	Closed	-$18.1M	–	516
2016 Q3	$18.1M	Sell	392,500 -85,225	-18%	-$4.45M	0.48%	78
2016 Q2	$24M	Sell	477,725 -505,225	-51%	-$26.9M	0.64%	52
2016 Q1	$52.6M	Buy	982,950 +228,885	+30%	+$13.4M	0.96%	24
2015 Q4	$49.5M	Buy	754,065 +95,555	+15%	+$5.91M	0.93%	32
2015 Q3	$37.2M	Buy	658,510 +216,850	+49%	+$14.1M	0.69%	54
2015 Q2	$26.1M	Buy	+441,660	New	+$27.2M	0.48%	83

Other funds holding TEVA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return